2017-11-17

[#DIV28SUPER] NINDS seeks a Director to lead its extramural Division of Neuroscience.

Director, Division of Neuroscience National Institute of Neurological Disorders and Stroke (NINDS):   NINDS seeks a Director to lead its extramural Division of Neuroscience.  The Director of the Division of Neuroscience will be responsible for planning and directing a program of extramural and collaborative research in neuroscience, guiding NINDS’s largest research portfolio and charting the future of a vibrant, growing neuroscience research community https://www.ninds.nih.gov/.  The Division of Neuroscience has a flat organizational structure and includes 29 Program Directors and 17 Analysts assigned to 6specific scientific clusters including Neurogenetics, Channels, Synapses and Circuits, Systems, Cognitive Neuroscience, Repair and Plasticity, Neurodegeneration, and Neural Environment http://intranet.ninds.nih.gov/employee/policies_procedures/extramural/manual/D_Pre_Award_Procedures/Cluster_PD_Interests.pdf.

 

The Director will also be responsible for coordinating NINDS’s neuroscience collaborations across multiple NIH Institutes and Centers and with other Federal and private partners.  The Director will be a primary advisor to the NINDS Director and will report to the NINDS Director. The Director of the Division of Neuroscience will lead a group of approximately 60 professional staff.  The research portfolio of the Division of Neuroscience includes an annual budget of over $1 billion dollars in grants and over $30 million in R&D contracts.  Salary will be commensurate with experience. The position will be filled under a Title 42(f) excepted service appointment and a full package of federal benefits will be provided.  If you are ready for an exciting leadership opportunity, please see the link to the detailed Vacancy Announcement under Jobs at NINDS https://www.ninds.nih.gov/About-NINDS/Jobs-NINDS

 

 

This is being sent on behalf of NINDS a sister institute at NIH by NIDA.  The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov   301-435-1309

 

 

2017-11-15

[#DIV28SUPER] Apportionment vote - Reminder to give all 10 of your votes to Division 28

To all Division 28 members:

You may have just received your apportionment ballot from APA. The subject line in your email should read 2017 Apportionment Ballot Election.  This is a very important vote that determines our Division's representation on APA council,  I am writing to ask you to consider allocating all 10 of your votes to Division 28 so that Division 28 continues to have a strong voice in council decisions and APA policy.  

Please note that the boxes to check and list the number of votes that you are allocating are above the name of our division rather than below it (a bit confusing in my opinion).

Thanks for your continued dedication and support!

Best regards,

David

David S. Festinger, Ph.D.


President, Division 28 - Psychopharmacology & Substance Abuse
American Psychological Association


PCOM provides email capability to all students, faculty, staff, and administration.  All emails and attached files transmitted between and among the foregoing are considered confidential. The emails and attached files are intended solely for the use of the individual or entity to which they are addressed and reading, disclosing, disseminating, distributing or copying by a recipient other than that named therein is strictly prohibited. Any email described herein that is received by an entity or individual to which it is not specifically addressed should be immediately deleted by the unnamed recipient.


_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

[#DIV28SUPER] Call for Nominations - Division 28 Awards

Dear Colleagues:  I am again writing to encourage you to submit nomination materials for APA Division 28 Awards for the 2018 APA meeting in San Francisco.  Attached you will find the official call for nominations with the detailed instructions for each of the three awards:  Med Associates Brady-Schuster Award, Young Psychopharmacologist Award and Outstanding Dissertation Award.  These awards are an excellent way to recognize your outstanding colleagues in science- both the young and more seasoned!  The Awards Committee looks forward to seeing this year’s nominees.  The deadline for materials is January 15, 2018.  

 

Regards,

 

Cathy Stanger

 

 

Catherine Stanger, Ph.D.

Associate Professor

Department of Psychiatry

Geisel School of Medicine at Dartmouth

46 Centerra Parkway

Suite 300, HB 7255

Lebanon, NH 03766

Catherine.stanger@dartmouth.edu

Phone 603-646-7023

Fax 603-448-5335

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

[#DIV28SUPER] Postdoctoral Fellowship

T32 POSTDOCTORAL POSITIONS

Co-Occurring Substance Use and Mental Health Disorders

Geisel School of Medicine at Dartmouth

 

The Geisel School of Medicine at Dartmouth offers a unique postdoctoral training program in a developing area of transdisciplinary/translational research, co-occurring substance use and other mental disorders (COD) http://geiselmed.dartmouth.edu/scd/The philosophy of this program asserts that to effectively impact the problems of addiction and mental illness, one must be fully aware of their co-existence, etiologies, phenomenology, and clinical manifestations. Moreover, knowledge of integrated clinical approaches and the healthcare systems that serve those with co-occurring disorders are necessary to inform the questions to be asked in laboratory, animal and human imaging and clinical research studies.

 

At Dartmouth, six interconnected groups from neuroscience through implementation research, and across multiple departments provide research opportunities in intervention research, including digital health interventions, and developmental, social, behavioral, neurobiological mechanisms of addiction and co-occurring disorders. Faculty include preeminent national/international leaders and PhD and MD investigators with strong histories of training scientists. Program faculty lead diverse projects funded by many NIH institutes (NIDA, NIAAA, NIMH, NCI, NCATS and NICHD).

 

Appointment: Typically 2 years.  Eligibility: Applicants must have completed their training in psychology, or a related discipline and be U.S. citizens or permanent residents. Trainees are selected on the basis of scholastic record and commitment to a career in research related to addiction and mental health.  Benefits: Stipend, medical insurance coverage, and travel funds supported by NIH Institutional Training Awards.  For more information:  Contact Dr. Alan Budney (alan.budney@dartmouth.edu).  To apply: Forward curriculum vitae, statement of research interests, and 3 letters of reference to Brian Goodness, Operations Assistant (Brian.D.Goodness@dartmouth.edu). 

 

 

Alan Budney, Ph.D.

Geisel School of Medicine at Dartmouth

Department of Psychiatry

One Medical Center Drive, HB 7459

Lebanon, NH  03756

Email: alan.j.budney@dartmouth.edu

http://geiselmed.dartmouth.edu/scd/

 

2017-11-13

[#DIV28SUPER] Second Call for Proposals: 2018 APA Convention in San Francisco

Second Call for Abstracts and Symposia: 2018 APA Convention in San Francisco, CA


Call for Proposals: http://www.apa.org/convention/index.aspx

Submission Portal: https://my.apa.org/apa/idm/login.seam

Divisional Deadline: December 1st (by 5pm EST) LESS THAN 3 WEEKS!

 

We are excited to encourage any and all basic science and clinical researchers to submit abstracts for the 126th annual American Psychological Association convention. This year's convention will be held in beautiful San Francisco, California on August 9-12, 2018.

 

We need your help in making this a strong and breakout convention that highlights the latest and greatest in clinical and basic science research. Make plans now to drink great coffee and dodge bicycles on the way to see terrific posters and presentations. Take pleasure in knowing that someone is tech-ing out on a cable car trying to get to YOUR AWESOME WORK.  Together we can make this happen!

 

The 2018 Division 28 program will provide multiple networking opportunities and will highlight several hot-topic areas, including the opioid crisis and cannabis legalization, and clinical and research tools, like non-invasive brain stimulation and data crowdsourcing. We especially welcome submissions dealing with topics related to substance abuse in diverse populations, but all submissions related to psychopharmacology and substance abuse are welcome. We hope to see submissions featuring the work of students, early career investigators and established investigators.

 

More information about the convention is available at: http://www.apa.org/convention/index.aspx. Abstracts for individual submissions are due December 1st (by 5pm EST) and can be submitted online here: https://my.apa.org/apa/idm/login.seam.

 

Please email me (michael.wesley@uky.edu) with questions and be on the lookout for announcements about craft beer and our awesome 2018 convention plans.

 

Michael Wesley, Ph.D.

 

2017-11-07

[#DIV28SUPER] Fwd: Early Career Travel Awards for 2018 APA Convention

FYI

Sent from my iPhone

Begin forwarded message:

From: "Hoeppner, Bettina,Ph.D." <BHOEPPNER@mgh.harvard.edu>
Date: November 7, 2017 at 4:15:38 PM CST
To: "fredblow@umich.edu" <fredblow@umich.edu>, "rgonzales@austin.utexas.edu" <rgonzales@austin.utexas.edu>, "grube@prev.org" <grube@prev.org>, "paula.hoffman@ucdenver.edu" <paula.hoffman@ucdenver.edu>, "horgan@brandeis.edu" <horgan@brandeis.edu>, "larimer@uw.edu" <larimer@uw.edu>, "leonard@ria.buffalo.edu" <leonard@ria.buffalo.edu>, "bmccool@wakehealth.edu" <bmccool@wakehealth.edu>, "bmccrady@unm.edu" <bmccrady@unm.edu>, "pmolin@lsuhsc.edu" <pmolin@lsuhsc.edu>, "peter_monti@brown.edu" <peter_monti@brown.edu>, "gar@pitt.edu" <gar@pitt.edu>, "eriley@mail.sdsu.edu" <eriley@mail.sdsu.edu>, "ryabinin@ohsu.edu" <ryabinin@ohsu.edu>, "sherk@missouri.edu" <sherk@missouri.edu>, "lspear@binghamton.edu" <lspear@binghamton.edu>, "mtaffe@scripps.edu" <mtaffe@scripps.edu>, "fvalenzuela@salud.unm.edu" <fvalenzuela@salud.unm.edu>, "woodward@musc.edu" <woodward@musc.edu>, "szemore@arg.org" <szemore@arg.org>
Subject: Early Career Travel Awards for 2018 APA Convention

Dear NIAAA T32 Directors,

 

NIAAA has a number of travel awards available for early stage investigators to attend the 126th Annual Convention of the American Psychological Association, which will be held August 9-12, 2018, in San Francisco, California.  Would you be able to post this call for submissions to your listserv to make your trainees available of this opportunity?

 

All the best,

 

Bettina

 

 

Dear Students, Post-docs, and Junior Faculty,

 

If you are doing research on alcohol use, we would like to invite you to apply for our early career travel award.  This award is for $750 to help defray costs to the 126th Annual Convention of the American Psychological Association, which will be held August 9-12, 2018, in San Francisco, California.  Awards are made possible through funding from the National Institute on Alcohol Abuse and Alcoholism (R13 AA022858; PI: Hoeppner), which seeks to foster the development of the next generation of alcohol researchers. 

 

To apply, simply submit your proposal via APA's online submission portal as you normally would

(http://www.apa.org/convention/proposals.aspx?tab=3).  You can submit directly to Division 50 (Addiction Psychology) or your home division.  APA's deadline for submission is December 1, 2017.

 

To be eligible for the travel award, proposals must focus on alcohol use or related problems.  If your proposal is accepted by your division for presentation, you can apply for the travel award by completing a short application form here: https://redcap.partners.org/redcap/surveys/?s=488JTE787YThe deadline for applying for the travel award is February 15, 2018.

 

If funded, presentations will be showcased at an Early Career Investigators Poster Session and Social Hour sponsored by the Society of Addiction Psychology (Division 50), Division 28 (Psychopharmacology and Substance Abuse), NIAAA, and NIDA.  That means that you will present your work twice at APA: during your regularly scheduled time, and additionally at our early career investigator poster session.

 

We strongly encourage you to apply.  We will be able to fund a total of 20 travel awards, and an additional 15 awards will be awarded for projects focusing on drug use other than alcohol through funding by the National Institute on Drug Abuse (R13DA038955; PI: Obasi).  The Early Career Investigators Poster Session and Social Hour is a superb opportunity to connect with your peers and leading scientists in the field of addiction.  Last year, we had over 160 attendees, including NIH staff (11) and members from 27 APA divisions, spanning the range from early to senior investigators.  We would love to have you be part at our 2018 Early Career Investigators Poster Session and Social Hour!

 

All the best,

 

Bettina Hoeppner

bhoeppner@mgh.harvard.edu

 

 

 

 

Bettina B. Hoeppner, Ph.D., MS

Assistant Professor of Psychology

Harvard Medical School

 

Director of Biostatistics, Center for Addiction Medicine

Massachusetts General Hospital

 

151 Merrimac Street, Boston MA 02114

Office: 617-643-1988

Fax: 617-643-1998

bhoeppner@mgh.harvard.edu

 

The information in this e-mail is intended only for the person to whom it is
addressed. If you believe this e-mail was sent to you in error and the e-mail
contains patient information, please contact the Partners Compliance HelpLine at
http://www.partners.org/complianceline . If the e-mail was sent to you in error
but does not contain patient information, please contact the sender and properly
dispose of the e-mail.

2017-11-06

[#DIV28SUPER] APA Handbook of Psychopharmacology

Posted on behalf of Suzette Evans.

Dustin

Contributor(s) needed for the Final Chapter of the new American Psychological Association publication: APA Handbook of Psychopharmacology

The APA Handbook of Psychopharmacology (edited by Suzette M. Evans, PhD and Kenneth M. Carpenter, PhD) will provide a working knowledge of basic pharmacology and psychopharmacology in a language suitable for the targeted readership, and summarize the current and emerging research and clinical evidence related to the pharmacologic treatment of mental health disorders. Although psychopharmacology is constantly changing, particularly as new medications emerge, this handbook will provide a solid foundation of the field specifically geared towards psychologists. Our target audience primarily includes established psychology researchers and practitioners, but the Handbook will also be of value to allied social and behavioral scientists, as well as professionals in complementary fields such as clinical social work and mental health counseling. Moreover, psychology graduate students will find the chapters in the Handbook extremely valuable for gaining a sound familiarity with major specialties across the field.

We have identified contributors for all of the content-driven chapters and the chapters are rolling in at a rapid pace. At this time, we are in need of suggestions/offers regarding contributors for a pivotal and final chapter of the Handbook: Future Directions in Theory, Research, Practice and Policy. We are looking for someone with a very broad and global viewpoint who would be able to speak to the changing landscape of psychologists in the treatment of mental health disorders.

If you are interested in writing this chapter or have suggestions of others who might be appropriate, please contact Suzette Evans directly at se18@cumc.columbia.edu. I am looking to identify someone as soon as possible so we can maintain our production schedule so please respond by November 15th, 2017.

_____________________ div28SUPER@lists.apa.org _____________________
Div28m members #div28 subscribers corner: http://lists.apa.org

2017-10-31

[#DIV28SUPER] Call for Proposals: 2018 APA Convention in San Francisco

Call for Abstracts and Symposia: 2018 APA Convention in San Francisco, CA


Call for Proposals: http://www.apa.org/convention/index.aspx

Submission Portal: https://my.apa.org/apa/idm/login.seam

Divisional Deadline: December 1st (by 5pm EST) 

 

We are excited to encourage any and all basic science and clinical researchers to submit abstracts for the 126th annual American Psychological Association convention. This year's convention will be held in beautiful San Francisco, California on August 9-12, 2018.

 

We need your help in making this a strong and breakout convention that highlights the latest and greatest in clinical and basic science research. Make plans now to drink great coffee and dodge bicycles on the way to see terrific posters and presentations. Take pleasure in knowing that someone is tech-ing out on a cable car trying to get to YOUR AWESOME WORK.  Together we can make this happen!

 

The 2018 Division 28 program will provide multiple networking opportunities and will highlight several hot-topic areas, including the opioid crisis and cannabis legalization, and clinical and research tools, like non-invasive brain stimulation and data crowdsourcing. We especially welcome submissions dealing with topics related to substance abuse in diverse populations, but all submissions related to psychopharmacology and substance abuse are welcome. We hope to see submissions featuring the work of students, early career investigators and established investigators.

 

More information about the convention is available at: http://www.apa.org/convention/index.aspx. Abstracts for individual submissions are due December 1st (by 5pm EST) and can be submitted online here: https://my.apa.org/apa/idm/login.seam.

 

Please email me (michael.wesley@uky.edu) with questions and be on the lookout for announcements about craft beer and our awesome 2018 convention plans.

 

Michael Wesley, Ph.D.

 

2017-10-30

[#DIV28SUPER] NIDA Diversity Outreach and Professional Development Programs

 

                                                                                                                                                                                

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov   301-435-1309

 

 

2017-10-26

[#DIV28SUPER] Position opening for Director of the University of New Mexico Center on Alcoholism, Substance Abuse and Addictions (CASAA)

Director, UNM Center on Alcoholism, Substance Abuse and Addictions (CASAA)

The University of New Mexico (UNM) is currently seeking a dynamic, innovative, results-oriented, senior addiction scientist for the position of Director of the Center on Alcoholism, Substance Abuse and Addictions (CASAA), one of UNM’s premier strategic research centers. The selected candidate will report directly to the Vice President for Research (VPR), and will be a tenured faculty member of the College of Arts and Sciences.

Minimum Qualifications

·        Ph.D., M.D., DrPH (or comparable terminal degree) in a field relevant to addictions research

·        Rank of Associate or Full Professor (or equivalent if not currently employed in an academic setting)

·        Strong record of research productivity in the addictions area

Preferred Qualifications

  • Demonstrated leadership and management skills in a highly productive research setting
  • Ability to articulate a vision for the future of addictions research and future directions for CASAA within that vision
  • Record of substantial successful funded research in the addictions field
  • Publication record commensurate with a senior scientist/faculty member
  • Solid plans to continue to have an active program of research
  • Record of successfully recruiting and mentoring investigators
  • Record of successfully teaching and mentoring students
  • Record of engagement with and leadership in the addictions field through, for example, editorial service, service on federal review committees, service on advisory panels or engagement with professional societies
  • Demonstrated success working collaboratively in partnership with colleagues across disciplines and/or sites
  • A demonstrated commitment to diversity, equity, inclusion and student success, as well as, working with broadly diverse communities

For complete details of this position, please visit http://casaadirectorsearch.unm.edu.

To apply, visit: https//unmjobs.unm.edu/ and reference: REQ2606

Best consideration date for applications:  December 15, 2017

 

The University of New Mexico is an Equal Opportunity/Affirmative Action employer and educator.

 

 

Katie Witkiewitz, PhD

Professor

Department of Psychology

Center on Alcoholism, Substance Abuse, and Addictions

MSC03-2220

University of New Mexico

Albuquerque NM 87131

Office phone: 505-277-5953

Vmail: 505-925-2334

Fax: 505-277-1394

http://casaa.unm.edu/kwitkiewitz.html

 

2017-10-21

[#DIV28SUPER] Opportunity for Doctoral Studies in Health Behavior with Research Focus on Addictions

Dear Colleagues and Students,

 

Faculty in the Department of Health Education and Behavior at the University of Florida (UF) are seeking doctoral students for their Ph.D. program in Health and Human Performance with Concentration in Health Behavior. The program is well suited to outstanding students who seek intensive research training and education pertaining to health psychology, public health and community-based research for whom clinical training is not a primary or immediate interest. Admission to the doctoral program comes with a graduate assistantship that provides a tuition waiver covering full-time coursework, health insurance, plus stipend.

 

The topic of addictions is a research strength throughout UF with international leaders in this area located throughout the university. Several faculty in the Department have research programs focused on the addictions, including Drs. Jalie Tucker, JeeWon Cheong, Robert Leeman, Richard Yi, Ali Yurasek and beginning in Spring 2018, Megan McVay. In particular, Drs. Leeman and Yurasek are actively seeking new doctoral students for Fall 2018.

 

Dr. Leeman’s research focus is on relationships between addictive behaviors and other difficulties with self-control. He and his collaborators contribute to understanding the etiology of addictions and in testing new interventions to ameliorate addictive behaviors. His research pertains primarily to the adolescent and young adult populations. Dr. Leeman’s group is currently conducting two NIH-funded studies to test mobile interventions to reduce alcohol use and related risky sexual behavior.

 

Dr. Yurasek’s primary research interests include using behavioral economic theory to identify risk factors for substance misuse and poor response to treatment as well as examining marijuana use amid the changing legal climate.

 

Interested students should contact Dr. Yurasek (a.yurasek@ufl.edu) or Dr. Leeman (robert.leeman@ufl.edu) directly to learn more about research and mentorship opportunities with their respective research groups. Students can learn more about the doctoral program on the web at  http://hhp.ufl.edu/about/academics/phd/heb-phd/ or by contacting Academic Advisor Ms. Jenny Neelands by email at jennifer4@ufl.edu or by phone at 352-294-1803 or Dr. Virginia Dodd, Associate Professor and Acting Graduate Coordinator by email at vdodd@dental.ufl.edu.  Review of applications will begin on November 1st but submission after that date is possible.

 

Thank you for your consideration.

 

 

 

Robert F. Leeman, Ph.D.
Associate Professor

Department of Health Education and Behavior

University of Florida

Florida Gymnasium, Room 14

PO Box 118210
Gainesville, FL  32611

Phone: (352) 294-1808

Fax: (352) 392-1909

Email: robert.leeman@ufl.edu

http://heb.hhp.ufl.edu/index.php/about-2/department-directory/leeman-robert/

 

2017-10-19

[#DIV28SUPER] NIDA Neuroscience Update, October 19, 2017

Table of Contents

I.                  Meet NIDA Staff at the Annual Meeting for Society For Neuroscience, Nov 10-16, 2017

II.               Exploiting HIV and/or Host Genomic Information to Understand HIV Compartments or Reactivation in Individuals with Substance Use Disorders (R61/R33) (RFA-DA-18-016)  Application Receipt Date:  December 13, 2017 by 5 pm local time of applicant organization.

III.              Request for Information (RFI): Seeking Input from Surgeons and Interventionalists on Improving the Clinical Study and Use of New and Established Peripheral Neuromodulation Devices  NOT-RM-17-023

IV.              Request for Information: Trans-NIH Strategic Plan for Research on Women’s Health

I.  Come meet NIDA Staff at the Annual Meeting Society for Neuroscience, Nov 10-16, 2017.  NIDA staff will be at the NIDA-NIAAA Mini-Convention, Friday Nov 10, 2017 Walter E. Washington Convention Center, Rm 207A, Washington, DC and at the NIDA Booth. To make an appointment with NIDA Staff to discuss a proposal or funding opportunities see email addresses below. 

Division of Neuroscience and Behavior

Office of the Director

email

telephone

Rita Valentino, Ph.D. Director

valentinorj@nida.nih.gov

301-827-5436

Roger Little, Ph.D. Deputy Director

alittle@nida.nih.gov

301-435-1316

Steven Grant, Ph.D. Coordinator for Translation, Cognitive Neuroscience, Neuroimaging

sgrant@nida.nih.gov

301-443-8869

Training

Beth Babecki, M.A., Lead coordinator: Training Hub, Basic F30, F31, F32, T32

bbabecki@mail.nih.gov

301-435-0899

Mary Kautz, Ph.D. Program Director: Clinical, T32

kautzm@nida.nih.gov

301-443-3206

Roger Sorenson, Ph.D., M.P.A., Program Director:  Basic K99/R00

rsorense@nida.nih.gov

301-443-3205

Yu (Woody) Lin, Ph.D., M.D. Program Director: Clinical K99/R00

ylin1@nida.nih.gov

301-435-1318

Behavioral and Cognitive Neuroscience Branch

Mary Kautz, Ph.D., Acting Chief,  TRSP Liason Behavioral Pharmacology, Nicotine

kautzm@nida.nih.gov

301-443-3206

Cora Lee Wetherington, Ph.D. Program Director: Women and Sex/Gender Differences- Research Coordinator; Sex/Gender Differences, Vulnerability, Development

cwetheri@nida.nih.gov

301-435-1319

Zu-In (Shelly) Su, Ph.D. Program Director: Cognition, Affect, Operant Behavior

shelley.su@nih.gov

301-402-3869

Integrative Neuroscience Branch

Roger Sorensen, Ph.D. , M.P.A., Chief, Molecular and Cellular Neurobiology, Neural Circuits, Glia

rsorense@nida.nih.gov

301-443-3205

Olivier Berton, Ph.D. Program Director: Cells, Circuits & Neuroplasticity in Motivation and Addiction

olivier.berton@nih.gov

301-827-7771

Vani Pariyadath, Ph.D., Program Director: Cognitive Neuroscience, Neuroimaging of addiction-related circuitry

pariyadathv@nida.nih.gov

301-443-3209

Vishnudutt Purohitt, D.V.M., Ph.D., Program Director: HIV, Inflammation and Immune System, Pain

vpurohit@nida.nih.gov

301-594-5753

Yu (Woody) Lin, Ph.D., Porgram Director: Cognitive Neuroscience, Neuro Aids, Pain, CNS Plasticity, Neuromodulation

ylin1@nida.nih.gov

301-435-1318

Chemistry, Pharmacology, and Physiological Systems Branch

Rao Rapaka, Ph.D. Chief, Medicinal Chemistry, Nanotechnology, ADME(PK//PD) and Systems Biology (proteomics, metabolomics, tyrptomics, Lipidomics, etc)

rrapaka@mail.nih.gov

301-435-1304

Kristopher Bough, Ph.D., Program Director and SBIR/STTR Division Coordinator: Basic Drug Discovery Program

boughk@nida.nih.gov

301-443-9800

Paul Hillery, Ph.D., Program Director: Organic and Medicinal Chemistry, Structural Biology

phillery@mail.nih.gov

301-435-1306

Genetics, Epigenetics, and Developmental Neuroscience Branch

Jonathan D. Pollock, Ph.D., Chief, Molecular Neuroanatomy, Genetics of Addiction, Molecular Basis of Memory, Molecular Genetics or Host Response

jpollock@mail.nih.gov

301-435-1309

Amy Lossie, Ph.D., Program Director: Bioinformatics, Statistical Genetics, Transposable Elements, Splicing, RNA binding Proteins.

amy.lossie@nih.gov

301-435-1308

John Satterlee, Program Director: Epigenetics, Non-coding RNAs, Model Organism Genetics, Functional Genomics, Signal Transduction

satterleej@mail.nih.gov

301-435-1020

Da-Yu Wu, Program Director: Neural Development, Gene Regulation

wudy@mail.nih.gov

301-435-4649

 

II. Exploiting HIV and/or Host Genomic Information to Understand HIV Compartments or Reactivation in Individuals with Substance Use Disorders (R61/R33)
(RFA-DA-18-016)  Application Receipt Date:  December 13, 2017 by 5 pm local time of applicant organization.

  • Purpose:  This initiative will support exploratory projects that exploit HIV or host genomic or nucleomic information to understand HIV latency in individuals with substance use disorders (SUDs).

 

  • NIDA intends to commit $2 million dollars in FY2018 to fund 3-4 awards

 

  • Application budgets are limited to $650,000 direct costs and must reflect the actual needs of the proposed project.

 

  • The R61/R33 grant mechanism includes an exploratory high risk/high pay off R61 phase (three years).  Near the end of the R61 phase, NIDA scientific staff will review progress made towards the proposed R61 milestones and recommend a subset of R61 projects for continued support through the R33 phase (two years) pending merit and the availability of funds

 

  • Nucleomics:  robust nuclear architecture assays (e.g. Hi-C, ChIA-PET, DamID, cellular imaging approaches) 

 

 

III. Request for Information (RFI): Seeking Input from Surgeons and Interventionalists on Improving the Clinical Study and Use of New and Established Peripheral Neuromodulation Devices  NOT-RM-17-023: The NIH SPARC (Stimulating Peripheral Activity to Relieve Conditions) program aims to enable the development of the next generation of neuromodulation devices informed by promoting the systematic development of high resolution neural circuit maps within organs and tissues of the peripheral nervous system. Therapeutic development may be stimulated by increasing the understanding of human peripheral neuroanatomy and its relationship to organ function, which may be facilitated by stronger linkages between clinical practice and basic research. To guide future efforts, SPARC is requesting input from surgeons, interventionalists, and other relevant clinicians on partnering to improve the clinical study of neuromodulation devices, specifically in applications involving peripheral or spinal neuromodulation of organ function. Comments should be provided by 1 December 2017.

 

IV.Request for Information: Trans-NIH Strategic Plan for Research on Women’s Health

The NIH Office of Research on Women’s Health has published a Request for Information (RFI) on the next Trans-NIH Strategic Plan for Research on Women’s Health.  It can be found in the NIH Guide (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-17-108.html).  A link within the RFI will take you to a form where you can submit your ideas.  Feedback is sought on 3 cross-cutting themes and goals under consideration:  (1) Expand the Exploration of Sex as a Biological Variable (SABV) in NIH Research, (2) A Multi-Dimensional Approach to the Science of Women's Health, and  (3) Quality of Life and Disease Burden over the Life-Course.  Your feedback is requested by November 10.

 

 The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov   301-435-1309